Register for updates

 
 

Medicine & Health
RSS Feed
Anti-Inflammatory, Anti-Stress Drugs Taken Prior to Surgery May Reduce Metastatic Recurrence
Monday, August 07, 2017 9:00:00 AM

The body's stress inflammatory response is an active agent of cancer metastasis, TAU researchers say

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

A new Tel Aviv University study finds that a specific drug regimen administered prior to and after surgery significantly reduces the risk of post-surgical cancer recurrence. These medications, a combination of a beta blocker (which relieves stress and high blood pressure) and an anti-inflammatory, may also improve the long-term survival rates of patients. The treatment is safe, inexpensive — two medications similar in price to aspirin — and easily administered to patients without contraindications.

The research was led by Prof. Shamgar Ben-Eliyahu of TAU's School of Psychological Sciences and Sagol School of Neuroscience in collaboration with Prof. Steven Cole of UCLA; Prof. Oded Zmora of Sheba Medical Center, Tel Hashomer; Prof. Eran Sharon of Rabin Medical Center, Beilinson; and Prof. Tanir Ellweiss of Kaplan Medical Center. It was published in Clinical Cancer Research.

Deviating from dogma

"We've taken an unconventional approach, deviating from the current medical dogma that refrains from intervening during the short period surrounding a cancer surgery — no chemo, radio or immune therapy for at least three weeks before or after surgery," Prof. Ben-Eliyahu said. "Even within the medical establishment, we encountered some levels of disbelief and antagonism. But after conducting ample studies in animal models of cancer, and reviewing the medical literature, we came to the firm conclusion that maybe this is the most important period in the prevention of cancer recurrence."

For the study, 38 breast cancer patients at Sheba Medical Center, Kaplan Medical Center and Rabin Medical Center were given a pharmacological treatment — Deralin (used to reduce blood pressure and anxiety) and Etopan (used to reduce inflammation) — five days before their surgeries, the day of their surgeries and five days after their surgeries. Blood and tumor tissue samples were then analyzed using whole genome gene expression profiling to identify all the RNAs expressed in malignant cells and leukocytes.

"We found that the drugs were very efficient in reducing biomarkers of metastatic processes," Prof. Ben-Eliyahu said. "For example, we found that the drug treatment reverses EMT — the process that tumor cells go through to slip out of the primary tumor and enter another organ. It is a crucially important step in the metastatic process. We also looked at indices related to the immune system and were able to improve immune competence and reduce inflammation with the drugs."

The research team has conducted a similar study, which has not yet been published, on colorectal cancer patients and has found similar results.

The researchers are currently considering a larger-scale clinical trial to establish the clinical long-term beneficial effects of this treatment. "Positive outcomes should validate this treatment and lead to its becoming available for most cancer patients," Prof. Ben-Eliyahu concluded.




Latest News

Binge Drinking in College May Lower Chances of Landing a Job After College

Drinking habits, not drinking itself, may impact future careers, say TAU, Cornell University researchers.

A New Alternative to "Practice Makes Perfect"

Brief reactivations of visual memories are enough to complete a full learning curve, TAU researchers say.

IDEAS Immersion Program to Host Six Startups from TAU in Chicago

Acceleration program partners with Chicago's 1871 Center for Technology and Entrepreneurship to help budding entrepreneurs incubate startups.

Citrus: From Luxury Item to Cash Crop

Citrus fruits were the clear status symbols of the nobility in the ancient Mediterranean, TAU researcher says.

A Social Aspect to the Inheritance of Differing Behaviors of Men and Women

New study from Melbourne, Exeter and Tel Aviv Universities suggests gender-specific behaviors can be inherited from social environment, not just from genetics.

Anti-Inflammatory, Anti-Stress Drugs Taken Prior to Surgery May Reduce Metastatic Recurrence

The body's stress inflammatory response is an active agent of cancer metastasis, TAU researchers say.

Cultural Activities May Influence the Way We Think

A new learning model may explain how culture helped shape human cognition and memory, TAU researcher says.

Marine Vessels are Unsuspecting Hosts of Invasive Species

Half of the ships passing along the Mediterranean coast of Israel carry damaging ascidians, TAU researchers say.

Inauguration of Steinhardt Museum of Natural History Celebrated at TAU on June 26

Historic event held in presence of philanthropist Michael Steinhardt and family, TAU governors, board members and faculty.

Baxter, Ramot at TAU and Tel Aviv Sourasky Medical Center Partner to Bring New Surgical Innovations Worldwide

Agreements will explore potential applications of promising early-stage research in areas of unmet need.

contentSecondary
c

© 2017 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University